-+ 0.00%
-+ 0.00%
-+ 0.00%

APTEVO THERAPEUTICS - REGULATORY INTERACTION PLANNED FOR 1H27 FOR MIPLETAMIG IN FRONTLINE AML - SEC FILING

Reuters·09/03/2026 12:17:11

Please log in to view news